Nadine Muskatel Tung
Associate Professor of Medicine
Medicine
Beth Israel Deaconess Medical Center
United States of America
Biography
Nadine M. Tung, M.D., is an Associate Professor of Medicine at Harvard Medical School, and the Director of the Cancer Risk and Prevention Program at the Beth Israel Deaconess Medical Center in Boston. She went to medical school at Harvard Medical School and completed her residency at Beth Israel Deaconess Medical Center, with a fellowship at Beth Israel Deaconess Medical Center.
Research Interest
Breast Cancer; Cancer genetics
Publications
-
Mizrahi M, Tseng JF, Wong D, Tung N, Eskander MF, Berzin TM, Pleskow DK, Sawhney MS. Chronic Pancreatitis–Like Change in BRCA2 Mutation Carriers. Pancreas. 2017 May 1;46(5):679-83.
-
Robson M, Im SA, Senkus E, Xu B, Domchek SM, Masuda N, Delaloge S, Li W, Tung N, Armstrong A, Wu W. Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation. New England Journal of Medicine. 2017 Jun 4.
-
Schnitt SJ, Morrow M, Tung NM. Refining Risk Assessment in Women With Benign Breast Disease: An Ongoing Dilemma. JNCI: Journal of the National Cancer Institute. 2017 Oct 1;109(10).
